Answers are grounded in this paper and cite their sources.
Evidence shows increased treatment limits for TMS may improve outcomes for patients with depression, suggesting policy change.
Objective To make a case for the Medicare benefits schedule (MBS) rule, that depressed patients who benefit from transcranial magnetic stimulation (TMS) have a lifetime limit of 50 treatments, to be reconsidered. Conclusion Evidence proves TMS can produce remission in major depressive disorder/treatment resistant disorder (MDD/TRD) when medication has failed. This is a relapsing disorder, and further treatments are usually required (but are prevented by this limit). We suggest the limit be raised to 70 treatments (2 courses, or similar) per year.
No takes yet. Share an insight, caveat, or question.
Pridmore et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: